Grant of Options

RNS Number : 0617J

Deltex Medical Group PLC

24 March 2010

Deltex Medical Group plc

Grant of options

24 March 2010 - Deltex Medical Group plc (the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that yesterday the Board approved the issue of share options to its executive members.

EMI scheme - Salary sacrifice

Following Ewan Phillips and Paul Mitchell's appointments as Chief Executive and Finance Director respectively in September 2009, they have both elected to sacrifice the whole of the corresponding salary increases awarded by the Company's Remuneration Committee in respect of the period 1 January 2010 to 31 March 2010, in return for awards of options under the Company's 2003 Enterprise Management Incentive ("EMI") Scheme as follows:

Name	Number	Exercise Price £	Exercise period	Total Number of EMI options held

Ewan Phillips	31,250	0.01	2009 - 2019	2,163,482

Paul Mitchell	22,531	0.01	2009 - 2019	181,539

Additional interests

Mr Phillips also has a beneficial interest in 1,159,773 ordinary shares in the Company representing 0.91 per cent of the issued ordinary share capital of the Company. Mr Phillips also holds options over 2,480,000 shares in the Company's Employee share option scheme. These options have a range of exercise periods from 2004 to 2019.

Mr Mitchell also holds options over 615,000 ordinary shares in the Company's Employee share option scheme. These options have a range of exercise periods from 2005 to 2019.

All shares and options relate to ordinary 1p shares.

For further information, please contact:-

Deltex Medical Group plc                                                                    01243 774 837
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director

Nominated Adviser and Broker 0207 614 5917

Arden Partners plc

Christopher Hardie

Matthew Armitt

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCLLFEDVEIVFII